fashion -WSS

fashion

author：Wikipedia 2025-10-01 10:59:31 - browse：2

The Chamber of Commerce in downtown Washington, DC. — The U.S. Chamber of Commerce sued to stop a new Medicare drug price negotiation program from going into effect. Adobe

WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in the first oral arguments in a lawsuit challenging the new law.

The two sides debated two questions: whether the Chamber of Commerce would be sufficiently injured by the law to file a lawsuit, and whether the negotiation program was a violation of drugmakers’ due process rights.

The hearing was held in the U.S. District Court for the Southern District of Ohio, and Judge Michael Newman, a Trump nominee, presided. Newman didn’t ask any questions of the attorneys, so the hearing didn’t provide any hints about which way he might be leaning on the issues.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 3 medical device trends to watch in 2024

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

How the first Native Hawaiian psychiatrist helped diversify medicine

Meadows told special counsel he could not recall Trump ever declassifying Mar

Federal weight loss drug coverage is 30 years out of date

FDA advisory panel to debate high blood pressure devices

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

leisure time

fashion

hotspot

The high cost of giving birth even with insurance

FDA advisory panel to debate high blood pressure devices

Wildfire smoke exposes gaps in outdoor worker protections

How a scoliosis diagnosis changed the life of one young dancer

Psychedelics group wrestles with new pharma identity

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

In age of alternative facts, a scholarly course on calling out crap

New weight loss drugs work. But how can they best be used?

As demand for Covid shots wanes, Moderna seeks its next success

GSK Flovent asthma inhalers replaced by authorized generics

focus

Former Pear Therapeutics executives start new VC firm

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

CDC says it’s too soon to assess risk posed by Covid subvariant

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Vivek Ramaswamy made waves in the debate, much as in biotech

focus

leisure time

leisure time

hotspot